Legal status · Australia
Is MET-233i legal in Australia?
No. MET-233i is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
MET-233i in Australia at a glance
| Classification | Investigational, not registered |
|---|---|
| TGA approval status | Not approved by TGA; investigational |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the MET-233i profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
MET-233i is being studied in registered clinical trials but has not received TGA marketing approval in Australia.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What MET-233i is
Pfizer's monthly amylin analog (from Metsera) with a 19-day half-life, being co-formulated with berobenatide into a once-monthly GLP-1 plus amylin combination.
MET-233i is an ultra-long-acting amylin receptor agonist that shares the albumin-binding platform used by berobenatide, designed for monthly dosing alone or with a GLP-1 agonist. 4% mean placebo-subtracted weight loss by day 36 as a monotherapy, with a 19-day observed half-life; those figures come from a company topline rather than a peer-reviewed publication.
Mechanism: Ultra-long-acting amylin receptor agonism, designed for monthly dosing alone or with a GLP-1 agonist.
Regulatory history: Investigational; Phase 2 (combination)
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for MET-233i at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
MET-233i in other countries
Frequently asked questions
Is MET-233i legal in Australia?
No. MET-233i is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Can I buy MET-233i in Australia?
No approved product exists to buy. In Australia MET-233i is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is MET-233i TGA approved?
No. In Australia MET-233i is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational; Phase 2 (combination). Evidence level: Preliminary.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for MET-233i live on its compound profile.
MET-233i profileThis page is general information about the regulatory status of MET-233i in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.